Suggested functions for prolyl oligopeptidase: a puzzling paradox.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2007-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CCA.2006.09.001PMID 17034776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: identification of an unusual cleavage site.

  2006cited by this paper
• Effect of Barley Endoprotease EP-B2 on Gluten Digestion in the Intact Rat

  2006cited by this paper
• Rational design of combination enzyme therapy for celiac sprue.

  2006cited by this paper
• S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies.

  2006cited by this paper
• Prolyl endopeptidase cleaves the apoptosis rescue peptide humanin and exhibits an unknown post-cysteine cleavage specificity.

  2006cited by this paper
• Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

  2005cited by this paper
• Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue.

  2005cited by this paper
• Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

  2005cited by this paper
• No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population.

  2005cited by this paper
• Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma

  2005cited by this paper
• How can the mood stabilizer VPA limit both mania and depression?

  2005cited by this paper
• Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy.

  2005cited by this paper
• Effect of Prolyl Endopeptidase Inhibition on Arginine‐Vasopressin and Thyrotrophin‐Releasing Hormone Catabolism in the Rat Brain

  2005cited by this paper
• Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.

  2005cited by this paper
• Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion

  2005cited by this paper
• Putative efficacy and dosage of prolyl endopeptidase for digesting and detoxifying gliadin peptides.

  2005cited by this paper
• “Coelionomics”: towards understanding the molecular pathology of coeliac disease

  2005cited by this paper
• Prolyl Endopeptidase-Mediated Destruction of T Cell Epitopes in Whole Gluten: Chemical and Immunological Characterization

  2005cited by this paper
• Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells.

  2005cited by this paper
• Search for substrates for prolyl oligopeptidase in porcine brain.

  2005cited by this paper
• Brain Prolyl Endopeptidase Expression in Aging, APP Transgenic Mice and Alzheimer’s Disease

  2005cited by this paper
• Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders

  2005cited by this paper
• Evolutionary relationships of the prolyl oligopeptidase family enzymes.

  2004cited by this paper
• Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients.

  2004cited by this paper
• Pyroglutamyl peptidase I and prolyl endopeptidase in human semen: increased activity in necrozoospermia.

  2004cited by this paper
• Serum Activity of Prolyl Endopeptidase, but Not of Dipeptidyl Peptidase IV, Is Decreased by Immunotherapy with IFN-α in High-Risk Melanoma Patients

  2004cited by this paper
• ZTTA, a Prolyl Endopeptidase Inhibitor, Potentiates the Arginine-Vasopressin-Induced Incorporation of [14C]Leucine in Rat Amygdaloid and Cortical Slices

  2004cited by this paper
• Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice.

  2004cited by this paper
• Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP

  2004cited by this paper
• Effect of Prolyl Endopeptidase on Digestive-Resistant Gliadin Peptides in Vivo

  2004cited by this paper
• Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.

  2004cited by this paper
• Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and α‐melanocyte‐stimulating hormone breakdown in the rat brain

  2003cited by this paper
• In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase.

  2003cited by this paper
• Intestinal digestive resistance of immunodominant gliadin peptides.

  2002cited by this paper
• Structural Basis for Gluten Intolerance in Celiac Sprue

  2002cited by this paper
• Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition.

  2002cited by this paper
• A common mechanism of action for three mood-stabilizing drugs

  2002cited by this paper
• Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation‐induced cell death

  2002cited by this paper
• Effects of the Prolyl Endopeptidase Inhibitor S 17092 on Cognitive Deficits in Chronic Low Dose MPTP-Treated Monkeys

  2002cited by this paper
• Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure.

  2001cited by this paper
• Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study.

  2001cited by this paper
• Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis.

  2001cited by this paper
• Acute doxorubicin (adriamycin) dosage does not reduce cardiac protein synthesis in vivo, but decreases diaminopeptidase I and proline endopeptidase activities.

  2001cited by this paper
• Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa.

  2001cited by this paper
• Brain prolyl oligopeptidase activity is associated with neuronal damage rather than β-amyloid accumulation

  2001cited by this paper
• The effects of aging on gene expression in the hypothalamus and cortex of mice.

  2001cited by this paper
• Trypanosoma cruzi Prolyl Oligopeptidase Tc80 Is Involved in Nonphagocytic Mammalian Cell Invasion by Trypomastigotes*

  2001cited by this paper
• Novel proline endopeptidase inhibitors do not modify Aβ40/42 formation and degradation by human cells expressing wild‐type and Swedish mutated β‐amyloid precursor protein

  2000cited by this paper
• Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi.

  2000cited by this paper
• Lithium therapy and signal transduction.

  2000cited by this paper
• Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate

  1999cited by this paper
• Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats.

  1999cited by this paper
• Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH.

  1999cited by this paper
• Early Prepubertal Ontogeny of Pulsatile Gonadotropin-Releasing Hormone (GnRH) Secretion: I. Inhibitory Autofeedback Control through Prolyl Endopeptidase Degradation of GnRH1.

  1999cited by this paper
• Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis.

  1999cited by this paper
• Inhibition of prolylendopeptidase does not affect gamma-secretase processing of amyloid precursor protein in a human neuroblastoma cell line.

  1999cited by this paper
• Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia.

  1998cited by this paper
• cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells.

  1998cited by this paper
• Effect of a prolyl endopeptidase inhibitor, JTP-4819, on radial maze performance in hippocampal-lesioned rats.

  1998cited by this paper
• Peptidases that Degrade Gonadotropin‐Releasing Hormone: Influence on LH Secretion in the Ewe

  1997cited by this paper
• Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse.

  1997cited by this paper
• Nuclear localization and involvement in DNA synthesis of Sarcophaga prolyl endopeptidase.

  1997cited by this paper
• Pharmacokinetics and safety of JTP-4819, a novel specific orally active prolyl endopeptidase inhibitor, in healthy male volunteers.

  1997cited by this paper
• Specific inhibitor for prolyl endopeptidase suppresses the generation of amyloid beta protein in NG108-15 cells.

  1997cited by this paper
• Z-321, a prolyl endopeptidase inhibitor, augments the potentiation of synaptic transmission in rat hippocampal slices.

  1997cited by this paper
• A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

  1997cited by this paper
• Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats.

  1997cited by this paper
• New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.

  1996cited by this paper
• Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and Body Fluids

  1996cited by this paper
• Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.

  1996cited by this paper
• ZTTA, a postproline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats.

  1996cited by this paper
• Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion.

  1996cited by this paper
• Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on thyrotropin-releasing hormone-like immunoreactivity in the cerebral cortex and hippocampus of aged rats.

  1995cited by this paper
• Effect of a Novel Prolyl Endopeptidase Inhibitor, JTP‐4819, on Prolyl Endopeptidase Activity and Substance P‐ and Arginine‐Vasopressin‐Like Immunoreactivity in the Brains of Aged Rats

  1995cited by this paper
• JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.

  1995cited by this paper
• Identification and localisation of a synaptosomal membrane prolyl endopeptidase from bovine brain.

  1995cited by this paper
• Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.

  1995cited by this paper
• Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats.

  1995cited by this paper
• A prolyl endopeptidase of Sarcophaga peregrina (flesh fly): its purification and suggestion for its participation in the differentiation of the imaginal discs.

  1994cited by this paper
• Heart prolyl endopeptidase activity in one-kidney, one clip hypertensive rats.

  1994cited by this paper
• Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts.

  1994cited by this paper
• Colocalization of prolyl endopeptidase and amyloid beta-peptide in brains of senescence-accelerated mouse.

  1994cited by this paper
• Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression.

  1994cited by this paper
• Pronounced increase in prolyl endopeptidase activity in primary cultures of rat cerebral cortex during neuronal differentiation.

  1994cited by this paper
• Stability of neurotensin and acetylneurotensin 8–13 in brush-border membrane, cytosol, and homogenate of rat small intestine

  1994cited by this paper
• Influence of Region‐Specific Alterations of Neuropeptidase Content on the Catabolic Fates of Neuropeptides in Alzheimer's Disease

  1994cited by this paper
• A survey of the cerebral regionalization and ontogeny of eight exo- and endopeptidases in murines.

  1993cited by this paper
• Purification and characterization of prolyl endopeptidase from rat skin.

  1993cited by this paper
• Protective effect of eurystatins A and B, new prolyl endopeptidase inhibitors, on scopolamine-induced amnesia in rats.

  1992cited by this paper
• Evidence that prolyl endopeptidase participates in the processing of brain angiotensin.

  1991cited by this paper
• Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis.

  1991cited by this paper
• Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism

  1991cited by this paper
• Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with alzheimer's disease

  1990cited by this paper
• Synthesis and inhibitory activity of acyl-peptidyl-prolinalderivatives toward post-proline cleaving enzyme as nootropic agents.

  1990cited by this paper
• Purification and characterization of prolyl endopeptidase from pig brain.

  1990cited by this paper
• Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line.

  1990cited by this paper
• Distribution of Alzheimer's disease amyloid A4-generating enzymes in rat brain tissue.

  1990cited by this paper
• Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain.

  1990cited by this paper
• Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase.

  1988cited by this paper
• Porcine muscle prolyl endopeptidase and its endogenous substrates.

  1988cited by this paper

• The prolyl oligopeptidase and α-synuclein connection revisited.

  2025cites this paper
• Investigating substrate binding mechanism in prolyl oligopeptidase through molecular dynamics

  2025cites this paper
• Decoding dissociation pathways of ligands in prolyl oligopeptidase.

  2025cites this paper
• Decoding Binding Pathways of Ligands in Prolyl Oligopeptidase

  2025cites this paper
• Synthesis of Novel Benzimidazole Analogs for Neurodegenerative Diseases by Targeting Prolyl Oligopeptidase

  2024cites this paper
• Proteomic Analysis Reveals Differential Protein Expression Induced by Inhibition of Prolyl Oligopeptidase in Filarial Parasites

  2022cites this paper
• The Protective Role of Prolyl Oligopeptidase (POP) Inhibition in Kidney Injury Induced by Renal Ischemia–Reperfusion

  2021cites this paper
• Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma

  2021cites this paper
• Hemoglobin-derived peptides and mood regulation.

  2020cites this paper
• The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy.

  2020cites this paper
• The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model

  2020cites this paper
• Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2)

  2020cites this paper
• Integrated Synthetic, Biophysical and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.

  2019cites this paper
• Insect gut as a bioresource for potential enzymes - an unexploited area for industrial biotechnology

  2019cites this paper
• The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.

  2019cites this paper
• Evaluation of prolyl oligopeptidase and acetylcholinesterase inhibition by Phyllanthus tenellus Roxb. from Brazil

  2019cites this paper
• Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent.

  2019cites this paper
• Changes in Gene Expression Profiles in Adult Rat Brain Structures after Neonatal Action of Dipeptidyl Peptidase-IV Inhibitors

  2018cites this paper
• Thimet oligopeptidase and prolyl endopeptidase of spotted scat Scatophagus argus: characterization, tissue distribution, expression at different ovarian stages and down-regulation by estradiol

  2018cites this paper
• Biosynthesis of the Amanita Cyclic Peptide Toxins

  2018cites this paper
• The Cyclic Peptide Toxins of Amanita and Other Poisonous Mushrooms

  2018cites this paper
• The expression of proline-specific enzymes in the human lung.

  2017cites this paper
• The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.

  2017cites this paper
• Chemical composition and evaluation of prolyl oligopeptidase and acetylcholinesterase inhibitory activities of Leonurus Sibiricus L. from Brazil

  2017influential citation
• Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

  2017cites this paper
• Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)

  2017cites this paper
• New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro

  2017cites this paper
• Effect of oxidation of the non-catalytic β-propeller domain on the substrate specificity of prolyl oligopeptidase from Pleurotus eryngii.

  2017cites this paper
• Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.

  2017cites this paper
• Biological Activities of Lasso Peptides and Structure–Activity Relationships

  2015cites this paper
• Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniques.

  2015cites this paper
• Computational Analysis of the Domain Architecture and Substrate-Gating Mechanism of Prolyl Oligopeptidases from Shewanella woodyi and Identification of Probable Lead Molecules

  2015cites this paper
• Prolyl Oligopeptidase Enhances α-Synuclein Dimerization via Direct Protein-Protein Interaction*

  2015cites this paper
• Lasso Peptides

  2015cites this paper
• Biochemical studies on trypanosomal prolyl oligopeptidase family pathogenic factors.

  2015cites this paper
• Correction for “ Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia

  2014cites this paper
• P-I class metalloproteinase from Bothrops moojeni venom is a post-proline cleaving peptidase with kininogenase activity: insights into substrate selectivity and kinetic behavior.

  2014cites this paper
• Decoding the structural events in substrate‐gating mechanism of eukaryotic prolyl oligopeptidase using normal mode analysis and molecular dynamics simulations

  2014cites this paper
• Computational analysis of the domain architecture and substrate-gating mechanism of prolyl oligopeptidases from Shewanella woodyi and identification probable lead molecules

  2014cites this paper
• Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice

  2014cites this paper
• Identification of prolyl oligopeptidase as a cyclosporine-sensitive protease by screening of mouse liver extracts

  2013cites this paper
• A Human XPC Protein Interactome—A Resource

  2013cites this paper
• Dual system for the central nervous system targeting and blood-brain barrier transport of a selective prolyl oligopeptidase inhibitor.

  2013cites this paper
• Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression.

  2013cites this paper
• Prolyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory.

  2013cites this paper
• Neuropeptidase activity is down-regulated by estradiol in steroid-sensitive regions of the hypothalamus in female mice.

  2012cites this paper
• Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney.

  2012cites this paper
• P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy.

  2012cites this paper
• Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase.

  2012cites this paper
• Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.

  2012cites this paper
• New insights to the brain functions of prolyl oligopeptidase

  2012influential citation
• Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.

  2012cites this paper
• Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner

  2011cites this paper
• Use of Umbrella Sampling to Calculate the Entrance/Exit Pathway for Z-Pro-Prolinal Inhibitor in Prolyl Oligopeptidase.

  2011cites this paper
• Structure and function relationship in prolyl oligopeptidase.

  2011cites this paper
• Role of prolyl endopeptidase in intracellular transport and protein secretion.

  2011cites this paper
• Prolyl Endopeptidase Is Involved in Cellular Signalling in Human Neuroblastoma SH-SY5Y Cells

  2011cites this paper
• Interaction of prolyl oligopeptidase with α-synuclein.

  2011cites this paper
• Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010

  2011cites this paper
• Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research.

  2011cites this paper
• Development of small molecule inhibitors for prolyl oligopeptidase

  2010cites this paper
• Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation

  2010cites this paper
• Sequential Expression, Activity and Nuclear Localization of Prolyl Oligopeptidase Protein in the Developing Rat Brain

  2010cites this paper
• Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.

  2010cites this paper
• Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances.

  2010cites this paper
• Prolyl endopeptidase mRNA expression in the central nervous system during rat development.

  2010cites this paper
• Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation.

  2010cites this paper
• Conversion of the anti-tumor agent tasidotin (ILX651) to its active metabolite by prolyl oligopeptidase

  2010cites this paper
• PROLYL OLIGOPEPTIDASE IN DEVELOPMENT

  2010cites this paper
• Prolyl oligopeptidase in multiple sclerosis

  2010cites this paper
• Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

  2010cites this paper
• Researcholigopeptidase is inhibited in relapsing-remitting multiple sclerosis

  2010cites this paper
• Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors.

  2009cites this paper
• Memory-enhancing drugs: a molecular perspective.

  2009cites this paper
• Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain.

  2009cites this paper
• A new side opening on prolyl oligopeptidase revealed by electron microscopy

  2009cites this paper
• Issues About the Physiological Functions of Prolyl Oligopeptidase Based on Its Discordant Spatial Association With Substrates and Inconsistencies Among mRNA, Protein Levels, and Enzymatic Activity

  2009cites this paper
• A Cost‐Effective Labeling Strategy for the NMR Study of Large Proteins: Selective 15N‐Labeling of the Tryptophan Side Chains of Prolyl Oligopeptidase

  2009cites this paper
• Putative "acylaminoacyl" peptidases from Streptomyces griseus and S. coelicolor display "aminopeptidase" activities with distinct substrate specificities and sensitivities to reducing reagent.

  2009cites this paper
• Molecular dynamics study of prolyl oligopeptidase with inhibitor in binding cavity

  2009cites this paper
• Processing of the Phalloidin Proprotein by Prolyl Oligopeptidase from the Mushroom Conocybe albipes*

  2009cites this paper
• Benzimidazolium Salts as Small, Nonpeptidic and BBB‐Permeable Human Prolyl Oligopeptidase Inhibitors

  2008cites this paper
• Localization of post-proline cleaving peptidases in Tenebrio molitor larval midgut.

  2008cites this paper
• Efficient access to enantiomerically pure cyclic alpha-amino esters through a lipase-catalyzed kinetic resolution.

  2008cites this paper
• Characterization of membrane‐bound prolyl endopeptidase from brain

  2008cites this paper
• Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).

  2008cites this paper
• Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules.

  2008cites this paper
• Plasma Activity of Prolyl Endopeptidase in Relation to Psychopathology During Immunotherapy with IFN-α in Patients with Renal Cell Carcinoma

  2008cites this paper
• Digestive peptidases in Tenebrio molitor and possibility of use to treat celiac disease

  2007cites this paper
• Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase

  2007cites this paper
• Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders.

  2007cites this paper
• Efficient access to N-protected derivatives of (R,R,R)- and (S,S,S)-octahydroindole-2-carboxylic acid by HPLC resolution

  2007cites this paper
• Cellular and Molecular Life Sciences the Amino Terminus Extension in the Long Dipeptidyl Peptidase 9 Isoform Contains a Nuclear Localization Signal Targeting the Active Peptidase to the Nucleus

  year unknowncites this paper